WebOct 5, 2024 · Separately, Agenus announced today that Dhan Chand, PhD, Head of Drug Discovery at Agenus was selected to present on the topic of enhanced CTLA-4 … WebMay 7, 2024 · Agenus Inc. (NASDAQ:AGEN) Q1 2024 Results Conference Call May 7, 2024 8:30 AM ETCompany Participants. Dr. Jennifer Buell - President and COO. Dr. …
Did you know?
WebDhan Chand. Agenus; Qun Wang. U.S. Food and Drug Administration; All co-authors (50) View All. Charles Kendall Stover. Department. Division of Infectious Disease; Gene Kurosawa. WebDhan CHAND, Senior Scientist Cited by 320 of Agenus, MA Read 48 publications Contact Dhan CHAND
WebMay 10, 2024 · Dhan Chand. As you are aware, Agenus is well familiar with the LT space. In fact, we built Merck ILT4 antibody MK-4830, which is progressing in the clinic, showing activity in patients that are ... WebNov 9, 2024 · LEXINGTON, Mass., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to ...
WebApr 6, 2024 · Dr. Jennifer Buell and Dr. Dhan Chand will also be available to discuss the Fc-engineering driving AGEN1181’s enhanced activity, and how the AACR presentations … WebSep 27, 2024 · View Dhan Chand's email address (d*****@agenus***.com) and phone number. Dhan works at Agenus as Scientific Director, Head of Drug Discovery. Dhan is based out of Lexington, Massachusetts, United States and works in the Biotechnology Research industry.
WebSenior Scientific Director, Head of Drug Discovery, Agenus Inc. - Cited by 414 - Cancer Immunology - Cell and Molecular Biology - Neuroscience - Endocrinology ... Dhan Chand. Senior Scientific Director, Head of Drug Discovery, Agenus …
WebJun 11, 2024 · Jeremy D Waight 1 , Dhan Chand 1 , Sylvia Dietrich 2 , Randi Gombos 1 , Thomas Horn 1 , Ana M Gonzalez 1 , Mariana Manrique 1 , Lukasz Swiech 1 , Benjamin Morin 1 ... 4 Agenus Inc., Lexington, MA 02421, USA. Electronic address: [email protected]. knowledge mediaWebOct 5, 2024 · Agenus Inc. announced the Company will present new data on its growing portfolio of clinical-stage immuno-oncology programs at the Society for Immunotherapy of Cancer 37th Annual Meeting, to be held November 8-12 in Boston, MA and virtually. ... Dhan Chand, PhD, Agenus’ Head of Drug Discovery, to present at SITC Targets for … redcastle vic weatherWebNov 13, 2024 · Dr. Jennifer Buell and Dr. Dhan Chand of Agenus will be available to discuss the next steps for AGEN1181 and indications selected for expansion. They will also discuss data from other programs ... redcat 03404WebFeb 9, 2024 · Agenus cautions investors not to place considerable reliance on the forward-looking statements contained in this release. ... Chief Medical Officer, and Dr. Dhan Chand, Scientific Director, Head ... redcastle walkWebNov 8, 2024 · Agenus (AGEN 0.68%) Q3 2024 Earnings Call ... So let me ask Dhan Chand, who is also here, to give you a very brief rationale based on extensive preclinical data, as well as the data from a similar ... redcastle trip advisorWebOct 5, 2024 · Separately, Agenus announced today that Dhan Chand, PhD, Head of Drug Discovery at Agenus was selected to present on the topic of enhanced CTLA-4 … redcastle swimming poolWebFeb 25, 2024 · Dhan Chand, PhD Our Next Wave of Innovation Agenus Investor Day 2024. Dhan Chand, PhD Our Next Wave of Innovation Agenus Investor Day 2024. Solutions . Video … knowledge merchandising pvt ltd unity plaza